Eric Raabe News Today

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of...

The Inflation Reduction Act, which was signed into law by President Biden on Wednesday, has given new life to efforts in the Pittsburgh region to limit the worst impacts of climate change.

A new report provides a road map and emissions data for Pittsburgh suburbs that want to reduce their greenhouse gas emissions. Together the 35 communities emit more greenhouse gases than Pittsburgh.

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) is set to have a busy few days at the American Association for Cancer Research (AACR) annual meeting in New...

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce new preclinical data...

Targeting abnormal cell metabolism may offer a way to treat aggressive brain tumors in kids, extending survival and boosting how well chemotherapy works.

Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of pediatric brain cancer.

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence ("A.I.") platform to transform oncology drug discovery and development, today announced a collaboration with Johns Hopkins Pediatric Oncology Division of The Sidney Kimmel Comprehensive Cancer Center and Dr. Eric Raabe, M.D., Ph.D. focused on Lanterns drug candidate LP-184 in the area of brain tumors, and specifically in Atypical Rhabdoid Tumors ("ATRT"), an u...